Functional and molecular aspects of renal prostaglandin receptors

Journal of the American Society of Nephrology

Volumn 7, Issue 1, 1996, Pages 8-17

  Breyer, Matthew D ^a,b,c   Jacobson, Harry R ^c   Breyer, Richard M ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; 11 DEOXY 16 PHENOXY 17,18,19,20 TETRANORPROSTAGLANDIN E1; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 [4 (1 HYDROXYHEXYL)PHENYL] 5 OXOCYCLOPENTANEHEPTANOIC ACID; 3 BENZYL 5 (6 CARBOXYHEXYL) 1 (2 CYCLOHEXYL 2 HYDROXYETHYLAMINO)HYDANTOIN; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; 7 (5 BENZYLOXY 2 MORPHOLINO 3 OXOCYCLOPENTYL) 5 HEPTENOIC ACID METHYL ESTER; 7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; AP 227; BUTAPROST; CICAPROST; FLUPROSTENOL; ILOPROST; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROSTANOID RECEPTOR; RAMATROBAN; SULPROSTONE; UNCLASSIFIED DRUG;

EDITORIAL; HUMAN; KIDNEY; PRIORITY JOURNAL;

EID: 0030047930     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (88)

1. Smith WL: Prostanoid biosynthesis and mechanisms of action. Am J Physiol 1992;263:F181-F191.
2. Dunn MJ, Hood VL: Prostaglandins and the kidney. Am J Physiol 1977;233:F169-F184.
3. Bonvalet JP, Pradelles P, Farman N: Segmental synthesis and actions of prostaglandins along the nephron. Am J Physiol 1987;253:F377-F387.
4. Lawrence RA, Jones RL: Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein. Br J Pharmacol 1992;105:817-824.
5. Coleman RA, Kennedy I, Humphrey PPA, Bunce K, Lumley P. Prostanoids and their receptors. In: Emmet JC, Ed. Comprehensive Medicinal Chemistry. Oxford: Pergamon Press; 1990;643-714.
6. Coleman RA, Smith WL, Narumiya S: VIII. International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994;46: 205-229.
7. Toh H, Ichikawa A, Narumiya S: Molecular evolution of receptors for eicosanoids. FEBS Lett 1995;361:17-21.
8. Hirata M, Hayashi Y, Ushikubi F, et al.: Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature 1991;349:617-620.
9. Namba T, Sugimoto Y, Negishi M, et al.: Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 1993;365:166-170.
10. Henderson R, Baldwin JM, Ceska TA, Zemlin F, Beckmann E, Downing KH: Model for the structure of bacteriorhodopsin based on high-resolution electron cryomicroscopy. J Mol Biol 1990;213:899-929.
11. Dixon RAF, Sigal IS, Strader CD: Structure-function analysis of the β-adrenergic receptor. Molecular biology of signal transduction. Cold Spring Harb Symp Quant Biol 1988;LIII:487-497.
12. O'Dowd BF, Lefkowitz RJ, Caron MG: Structure of the adrenergic and related receptors. Annu Rev Neurosci 1989;12:67-83.
13. Hausdorf WP, Campbell PT, Ostrowski J, Yu SS, Caron MG, Lefkowitz RJ: A small region of the β-adrenergic receptor is selectively involved in its rapid regulation. Proc Natl Acad Sci USA 1991;88:2979-2983.
14. Hausdorf WP, Caron MG, Lefkowitz RJ: Turning off the signal: Desensitization of β-adrenergic receptor function. FASEB J 1990;4:2881-2889.
15. Bouvier M, Hausdorf WP, Deblasi A, et al.: Removal of phosphorylation sites from the β2-adrenergic receptor delays onset of agonist-promoted desensitization. Nature 1988;333:370-373.
16. 2 receptors: Distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation. J Pharmacol Exp Ther 1991; 258:74-81.
17. 2 receptor from human blood platelets. J Biol Chem 1989;264:16496-16501.
18. 2 receptor. J Biol Chem 1994;69:19256-19261.
19. 2 receptor: cDNA cloning, expression and Northern blot analysis. Biochem Biophys Res Commun 1992;84:1197-1203.
20. Abe T, Takeuchi K, Abe K: Rat kidney thromboxane A2 receptor: Molecular cloning and expression. J Am Soc Nephrol 1993;4:81.
21. Wilkes BM, Solomon J, Maita M, Mento PF: Characterization of glomerular thromboxane receptor sites in the rat. Am J Physiol 1989;256:F1111-F1116.
22. Spurney RF, Onorato JJ, Albers FJ, Coffman TM: Thromboxane binding and signal transduction in rat glomerular mesangial cells. Am J Physiol 1993;264: F292-F299.
23. 22a. Abe T, Takeuchi K, Takahashi N, Tsutsumi E, Taniyama Y, Abe K: Rat kidney thromboxane receptor: Molecular cloning, signal transduction, and intrarenal expression localization. J Clin Invest 1996;72:657-664.
24. Badr KF: Sepsis-associated renal vasoconstriction: Potential targets for future therapy. Am J Kidney Dis 1992;20:207-213.
25. DeRubertis FR, Craven PA: Activation of protein kinase C in glomerular cells in diabetes: Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 1994;43:1-8.
26. Spurney RF, Ruiz P, Pisetsky DS, Coffman TM: Chronic thromboxane receptor blockade reduces renal imjury in murine lupus nephritis. Kidney Int 1992;41:973-982.
27. Stokes JB: Modulation of vasopressin-induced water permeability of the cortical collecting tubule by endogenous and exogenous prostaglandins. Miner Electrolyte Metab 1985;11:240-248.
28. Abramovitz M, Boie Y, Nguyen T, et al.: Cloning and expression of a cDNA for the human prostanoid FP receptor. J Biol Chem 1994;269:2632-2636.
29. Mene P, Simonson MS, Dunn MJ: Physiology of the mesangial cell. Physiol Rev 1989;69:1347-1424.
30. Breyer MD, Jacobson HR, Noland TD, et al.: Evidence that separate prostaglandin E2 (PGE2) receptors couple to cyclic AMP (cAMP) generation and intracellular calcium ([Ca++)i) in the rabbit cortical collecting duct. J Am Soc Nephrol 1992;3:452.
31. Funk C, Furchi L, FitzGerald G, et al.: Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. J Biol Chem 1993;268:26767-26772.
32. Breyer RM, Emeson RB, Breyer MD, Abromson RM, Davis LS, Ferrenback SM: Alternative splicing generates multiple isoforms of a rabbit prostaglandin E2 receptor. J Biol Chem 1994;298:6163-6169.
33. Sugimoto Y, Namba T, Negishi M, Ichikawa A, Narumiya S: Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J Biol Chem 1992;267: 6463-6466.
34. Toto RD, Anderson SA, Brown-Cartwright D, Kokko JP, Brater DC: Effects of acute and chronic dosing of NSAIDs in patients with renal insufficiency. Kidney Int 1986;30: 760-768.
35. Sedor JR, Davidson EW, Dunn MJ: Effects of nonsteroidal anti-inflammatory drugs in healthy subjects. Am J Med 1986;81[Suppl 2B]:58-70.
36. Schlondorff D: Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int 1993;44:643-653.
37. Patrono C, Dunn MJ: The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int 1987; 32:1.
38. 2 receptor from renal medulla with a pertussis toxin-reactive guanine nucleotide regulatory protein. J Biol Chem 1986;261:13430-13439.
39. Eriksen EF, Richelsen B, Gesser BP, Jacobsen NO, Stengaard-Pedersen K: Prostaglandin E2 receptors in the rat kidney: Biochemical characterization and localization. Kidney Int 1987;32:181-186.
40. Eriksson LO, Larsson B, Hedlund H, Andersson KE: Prostaglandin E2 binding sites in human renal tissue: Characterization and localization by radioligand binding and autoradiography. Acta Physiol Scand 1990;139: 393-404.
41. 2 binding sites in rat kidney. Acta Physiol Scand 1990;139:405-415.
42. Regan JW, Bailey TJ, Pepperl DJ, et al.: Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol Pharmacol 1994;46:213-220.
43. Coleman RA, Grix SP, Head SA, Louttit JB, Mallett A, Sheldrick RLG: A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins 1994;47:151-168.
44. Sonnenburg WK, Zhu J, Smith WL: A prostaglandin E receptor coupled to a pertussis toxin-sensitive guanine nucleotide regulatory protein in rabbit cortical collecting tubule cells. J Biol Chem 1990;265:8479-8483.
45. Sonnenburg WK, Smith WL: Regulation of cyclic AMP metabolism in rabbit cortical collecting tubule cells by prostaglandins. J Biol Chem 1988;263:6155-6160.
46. Yamaguchi DT, Hahn TJ, Beeker TG, Kleeman CR, Muallem S: Relationship of cAMP and calcium messenger systems in prostaglandin-stimulated UMR-106 cells. J Biol Chem 1988;263:10745-10753.
47. Hebert RL, Jacobson HR, Breyer MD: Prostaglandin E2 inhibits sodium transport in the rabbit CCD by raising intracellular calcium. J Clin Invest 1991;87:1992-1998.
48. Hebert RL, Jacobson HR, Fredin D, Breyer MD: Evidence that separate PGE2 receptors modulate water and sodium transport in rabbit cortical collecting duct. Am J Physiol 1993;265:F643-F650.
49. Watabe A, Sugimoto Y, Irie A, et al.: Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. J Biol Chem 1993;268:20175-20178.
50. Fowler B, Jacobson H, Breyer R, Breyer M: The Ca++ - coupled effects of prostaglandin E2 in the collecting duct are mediated by an EP1 receptor [Abstract]. J Invest Med 1995;43:356A.
51. Sugimoto Y, Namba T, Shigemoto R, Negishi M, Ichikawa A, Narumiya S: Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney. Am J Physiol 1994;266:F823-F828.
52. Chaudhari A, Kirschenbaum MA: Specific prostaglandin E2 binding sites in isolated rat glomeruli: Evidence for glomerular PGE receptors [Abstract]. Prostaglandins Leukot Med 1985;20:55A.
53. Chaudhari A, Gupta S, Kirschenbaum M: Biochemical evidence for PGI2 and PGE2 receptors in the rabbit renal preglomerular microvasculature. Biochim Biophys Acta 1990;1053:156-161.
54. Kirschenbaum MA: Prostanoids and renal failure. A hypothetical role for prostanoids in progressive renal disease. Contrib Nephrol 1986;50:36-45.
55. Plante GE, Breyer MD, Jacobson HR, Heber RL: Distinct effects of PGE2 and the receptor selective PGE2 analog sulprostone (SLP) on renal hemodynamics, urine volume and Na+ excretion in the rabbit [Abstract]. J Am Soc Nephrol 1991;2:525.
56. Yang J, Xia M, Goetzl E, Songzhu A: Cloning and expression of the EP3-subtype of human receptors for prostaglandin E2. Biochem Biophys Res Commun 1994; 98:999-1006.
57. Irie A, Sugimoto Y, Namba T, et al.: Third isoform of the prostaglandin-E-receptor EP3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase. Eur J Biochem 1993;26:217.
58. Negishi M, Sugimoto Y, Irie A, Narumiya S, Ichikawa A: Two isoforms of prostaglandin E receptor EP3 subtype. Different COOH-terminal domains determine sensitivity to agonist-induced desensitization. J Biol Chem 1993; 268:9517-9521.
59. Adam M, Boie Y, Rushmore TH, et al.: Cloning and expression of three isoforms of the human EP3 prostanoid receptor. FEBS Lett 1994;338:170-174.
60. Kunapuli SP, Mao GF, Bastepe M, et al.: Cloning and expression of a prostaglandin E receptor EP3 subtype from human erythroleukemia cells. Biochem J 1994; 298:263-267.
61. Regan JW, Bailey TJ, Donello JE, et al.: Molecular cloning and expression of human EP3 receptors: Evidence for three variants with different termini. Br J Pharmacol 1994;112:6163-6169.
62. Schmid A, Thierauch K-H, Schleuning W-D, Dinter H: Splice variants of the human EP3 receptor for prostaglandin E2. Eur J Biochem 1995;228:23-30.
63. Sugimoto Y, Negishi M, Hayashi Y, et al.: Two isoforms of the EP3 receptor with different carboxyl-terminal domains. J Biol Chem 1993;268:2712-2718.
64. Breyer MD, Jacobson HR, Davis LS, Breyer RM: In situ hybridization and localization of mRNA for the rabbit prostaglandin EP3 receptor. Kidney Int 1993;43:1372-1378.
65. Takeuchi K, Abe T, Takahashi N, Abe K: Molecular cloning and intrarenal localization of rat prostaglandin E2 receptor EPS subtype. Biochem Biophys Res Comm 1993;194:885-891.
66. Stokes JB: Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle. J Clin Invest 1979;64:495-502.
67. Honda A, Sugimoto Y, Namba T, et al.: Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J Biol Chem 1993;268:7759-7762.
68. Nishigaki N, Negishi M, Honda A, et al.: Identification of prostaglandin E receptor "EP2" cloned from mastocytoma cells as EP4 subtype. FEBS Lett 1995;364:339-341.
69. Bastien L, Sawyer N, Grygorczyk R, Metters KM, Adam M: Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype. J Biol Chem 1994;269:11873-11877.
70. Edwards RM: Effects of prostaglandins on vasoconstrictor action in isolated renal arterioles. Am J Physiol 1985;248:F779-F784.
71. Chatziantoniou C, Arendshorst WJ: Impaired ability of prostaglandins to buffer renal vasoconstriction in genetically hypertensive rats. Am J Physiol 1992;32:F573-F580.
72. Chatziantoniou C, Arendshorst WJ: Renal vascular reactivity to vasodilator prostaglandins in genetically hypertensive rats. Am J Physiol 1992;31:F124-F130.
73. 2 on the cell cyclic AMP content in the thin descending limb of Henle of the rat. Miner Electrolyte Metab 1984;10:21-25.
74. Torikai S, Kurokawa K: Distribution of prostaglandin E2-sensitive adenylate cyclase along the rat nephron. Prostaglandins 1981;21:427-435.
75. Nakao A, Allen ML, Sonnenburg WK, Smith WL: Regulation of cAMP metabolism by PGE2 in cortical and medullary thick ascending limb of Henle's loop. Am J Physiol 1989;256:C652-C657.
76. Grantham JJ, Burg MB: Effect of prostaglandin E1 on the permeability response of the isolated collecting tubule to vasopressin, adenosine 3′5′-monophosphate, and theophylline. J Clin Invest 1968;47:1154-1161.
77. Schafer JA, Troutman SL: cAMP mediates the increase in apical membrane Na+ conductance produced in rat CCD by vasopressin. Am J Physiol 1990;259:F823-F831.
78. Namba T, Oida H, Sugimoto Y, et al.: cDNA cloning of a mouse prostacyclin receptor: Multiple signaling pathways and expression in thymic medulla. J Biol Chem 1994;269:9986-9992.
79. Boie Y, Rushmore TH, Darmon-Goodwin A, et al.: Cloning and expression of a cDNA for the human prostanoid IP receptor. J Biol Chem 1994;269:12173-12178.
80. Hébert R, Regnier L, Peterson L: Rabbit cortical collecting ducts express a novel prostacyclin receptor. Am J Physiol 1995;268:F145-F154.
81. Bolger PM, Einser GM, Ramwell PW, Slotkoff LM, Corey EJ: Renal action of prostacyclin. Nature 1978;271:467-469.
82. Ito S, Carretero O, Abe K, Beierwaltes WH, Yoshinaga K: Effect of prostanoids on renin release from rabbit afferent arterioles with and without macula densa. Kidney Int 1989;35:1138-1144.
83. Veis JH, Dillingham MA, Berl T: Effects of prostacyclin on the cAMP system in cultured rat inner medullary collecting duct cells. Am J Physiol 1990;258:F1218-F1223.
84. Lewis RA, Soter NA, Diamond PT, Austen KF, Dates JA, Roberts LJ: Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 1982;129:1627-1631.
85. Eling TE, Danilowicz RM, Henke DC, Sivarajah K, Yankaskas JR, Boucher RC: Arachidonic acid metabolism by canine tracheal epithelial cells. Product formation and relationship to chloride secretion. J Biol Chem 1986;261:12841-12849.
86. Hirata M, Kakizuka A, Aizawa M, Hayashi Y, Ushikubi F, Narumiya S: Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proc Natl Acad Sci USA 1994;91:11192-11196.
87. Rao PS, Cavanagh D, Dietz JR, Marsden K, O'Brien WF, Spaziani E: Dose-dependent effects of prostaglandin D2 on hemodynamics renal function, and blood gas analyses. Am J Obstet Gynecol 1987;156:843-851.
88. Leff P, Giles H: Classification of platelet and vascular prostaglandin D2 (DP) receptors: Estimation of affinities and relative efficacies for a series of novel bicyclic ligands. Br J Pharmacol 1992;106:996-1003.